We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SYENS:EURONEXT BRUSSELSSyensqo SA/NV Analysis

Data as of 2026-03-11 - not real-time

€49.85

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Syensqo is trading at €49.85, well below its DCF‑derived fair value of €62.16, indicating a sizable upside potential. The stock sits under the 20‑day SMA (≈€66.76) and the 50‑day SMA (≈€69.86), confirming a bearish price trend, while the RSI of 21.6 signals that the shares are deeply oversold. Momentum indicators are negative, with the MACD line at –6.84 versus a signal line of –4.55, producing a bearish histogram. However, volume is increasing, and the price is only modestly above the identified support level of €47.69, suggesting a possible near‑term bottom.
Fundamentally, the company generates €6.54 bn in revenue but is experiencing a 7.7% decline YoY and a negative profit margin (‑0.7%). Despite earnings loss, operating cash flow of €871 m and free cash flow of €571 m remain solid, and the balance sheet shows ample cash (€1.37 bn) against debt (€2.97 bn). The dividend yield of 3.25% is supported by an extremely low payout ratio of 7.7%, implying sustainability. Low beta (0.14) points to limited market‑wide volatility, yet the 30‑day price volatility exceeds 112%, and thin trading volumes create liquidity concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical indicators (MACD, SMA) but oversold RSI suggests limited downside
  • Proximity to support at €47.69 with increasing volume
  • High short‑term volatility (112% 30‑day) and low liquidity

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to DCF fair value and price‑to‑book (0.82)
  • Strong cash generation and sustainable dividend yield
  • Potential sector recovery and demand for advanced materials

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Attractive dividend yield with very low payout ratio
  • Low market beta combined with solid balance sheet
  • Strategic positioning in high‑growth specialty chemicals and renewable materials

Key Metrics & Analysis

Financial Health

Revenue Growth-7.70%
Profit Margin-0.72%
ROE-0.64%
ROA2.99%
Debt/Equity43.79
P/B Ratio0.8
Op. Cash Flow€871.0M
Free Cash Flow€571.1M

Technical Analysis

TrendBearish
RSI21.6
Support€47.69
Resistance€81.17
MA 20€66.76
MA 50€69.86
MA 200€70.21
MACDBearish
VolumeIncreasing
Fear & Greed Index76.86

Valuation

Fair Value€62.16
GradeUndervalued
TypeValue
Dividend Yield3.25%

Risk Assessment

Beta0.14
Volatility112.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.